Kannt; Aimo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kannt; Aimo.The latest application filed is for "glp-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis".

Company Profile

1.13.16

Kannt; Aimo - Frankfurt am Main DE
Kannt; Aimo - Dreieich DE
Kannt; Aimo - Frankfurt DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis Grant 11,352,405 - Kannt , et al. June 7, 2	2022-06-07
Glp-1/glucagon Receptor Agonists In The Treatment Of Fatty Liver Disease And Steatohepatitis App 20200216510 - KANNT; Aimo ; et al.	2020-07-09
A Novel Soluble Biomarker For Insulin Resistance App 20170082643 - Kannt; Aimo ; et al.	2017-03-23
Substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors Grant 9,133,181 - Hachtel , et al. September 15, 2	2015-09-15
Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine Derivatives As Kinase Inhibitors App 20150133432 - HACHTEL; Stephanie ; et al.	2015-05-14
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors Grant 8,846,712 - Loehn , et al. September 30, 2	2014-09-30
Isoquinoline derivatives Grant 8,722,671 - Plettenburg , et al. May 13, 2	2014-05-13
Cycloalkylamine substituted isoquinoline derivatives Grant 8,710,228 - Plettenburg , et al. April 29, 2	2014-04-29
6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors Grant 8,686,150 - Hachtel , et al. April 1, 2	2014-04-01
Isoquinoline derivatives Grant 8,501,736 - Plettenburg , et al. August 6, 2	2013-08-06
6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors App 20130150340 - PLETTENBURG; Oliver ; et al.	2013-06-13
Method For Identifying A Compound Having An Antiarrhythmic Effect As Well As Uses Relating Thereto App 20130123143 - Kannt; Aimo ; et al.	2013-05-16
6-(4-Hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors App 20130085128 - HACHTEL; Stephanie ; et al.	2013-04-04
6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS App 20130065894 - LOEHN; Matthias ; et al.	2013-03-14
Cyclohexylamin Isoquinolone Derivatives App 20110251226 - Plettenburg; Oliver ; et al.	2011-10-13
Isoquinoline Derivatives App 20110245248 - Plettenburg; Oliver ; et al.	2011-10-06
Use of IRS-polypeptides for identifying of pharmaceutically active compounds Grant 7,732,151 - Tennagels , et al. June 8, 2	2010-06-08
Cycloalkylamine substituted isoquinoline derivatives App 20100081671 - PLETTENBURG; Oliver ; et al.	2010-04-01
Isoquinoline Derivatives App 20090088429 - PLETTENBURG; Oliver ; et al.	2009-04-02
Use of IRS-polypeptides for identifying of pharmaceutically active compounds App 20080020399 - Tennagels; Norbert ; et al.	2008-01-24
High-throughput-assay with high sensitivity for measuring of the activity of .beta.-adrenergic receptor kinase and for determining the impact of test substances on such activity Grant 7,279,286 - Kannt , et al. October 9, 2	2007-10-09
High-throughput-assay with high sensitivity for measuring of the activity of beta-adrenergic receptor kinase and for determining the impact of test substances on such activity App 20050059098 - Kannt, Aimo ; et al.	2005-03-17
High throughput screening method and assay system for determining the interaction between C-reactive protein and components binding to it App 20030232394 - Kannt, Aimo ; et al.	2003-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.